Novel HDAC inhibitors exhibit pre-clinical efficacy in lymphoma models and point to the importance of CDKN1A expression levels in mediating their anti-tumor response
暂无分享,去创建一个
L. Cascione | A. Stathis | E. Gaudio | E. Zucca | A. Mensah | I. Kwee | F. Bertoni | M. Ponzoni | A. Rinaldi | G. Fossati | G. Caprini